Hong Kong SAR

Chinese property management firm Sino-Ocean Service Holding has scooped up HK$1.74bn ($224.5m) after pricing its IPO below the mid-point of the marketed range.

GlobalCapital and Standard Chartered hosted a combination of virtual and in-person roundtable on the China high yield debt market at the end of November. The third part of a 2020 series followed the first roundtable in April and the second in July. This time around, leading experts came together to discuss the opportunities and outlook for the Mainland’s high yield bond market.

Chinese detergent maker Blue Moon Group has raised HK$9.8bn ($1.27bn) from its Hong Kong IPO, which saw a strong turnout from global and local investors.

Former JP Morgan banker Luke Lee has joined Sumitomo Mitsui Banking Corp’s Hong Kong office in a senior position.

Hong Kong's CK Asset Holdings made a rapid comeback to the fixed-for-life bond structure this week, raising $500m from a new outing on Tuesday.

Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn).

Crédit Agricole’s Benjamin Lamberg has been appointed as the bank’s new Taiwan chief executive officer, GlobalCapital Asia has learnt.

Chinese financial technology company Bairong is targeting Hong Kong for its IPO, having filed a draft prospectus with the city’s bourse.

Hong Kong’s personal loan provider, United Asia Finance, has returned to the market for its annual borrowing. It is seeking a HK$1.2bn ($154.8m) facility.

Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.

Vesync, a home appliance retailer, kicked off the roadshow for its up to HK$1.55bn ($200.1m) IPO in Hong Kong on Monday, with the company's growth story during the pandemic expected to appeal to investors.

Medical device maker LifeTech Scientific Corp tapped the Hong Kong market for HK$930m ($120m) in fresh equity on Thursday.